Phosphorus oxide (P4O10) → 5,6-Dimethyl-3-thia-1,4,7,8a-tetraaza-as-indacene

HRID 1051432ノート

反応式

HRID 1051432 の反応式
[CH3:1][C:2]1[N:3]=[CH:4][N:5]([C:7]2[N:8]=[CH:9][S:10][C:11]=2[NH:12][C:13](=O)[CH3:14])[CH:6]=1.O=P12OP3(OP(OP(O3)(O1)=O)(=O)O2)=O>P(Cl)(Cl)(Cl)=O>[CH3:14][C:13]1[C:6]2[N:5]([CH:4]=[N:3][C:2]=2[CH3:1])[C:7]2[N:8]=[CH:9][S:10][C:11]=2[N:12]=1

参加物

4

反応物 2

HCID 14812Phosphorus oxide (P4O10)HCID 86715562N-(4-(4-methyl-1H-imidazol-1-yl)thiazol-5-yl)acetamide

生成物 1

HCID 734258605,6-Dimethyl-3-thia-1,4,7,8a-tetraaza-as-indacene収率 33%

試薬・触媒・溶媒 1

HCID 24813Phosphorus oxychloride溶媒

反応条件

温度
160 °C

実験手順

N-(4-(4-methyl-1H-imidazol-1-yl)thiazol-5-yl)acetamide (50 mg, 0.23 mmol) was suspended in phosphorus oxychloride (5 mL) and P2O5 (326 mg, 2.3 mmol) was added quickly. The resulting mixture was heated at 160° C. in a sealed tube for 24 hr. After POCl3 was evaporated, the residue was quenched with ice water very carefully. The mixture was neutralized with saturated Na2CO3 solution and extracted with ethyl acetate. The organic layer was dried over Na2SO4, concentrated (the crude product can also be directly used for next step), purified by prep-HPLC to give 15 mg of the title compound (yield: 33%).

後処理

  1. customAfter POCl3 was evaporated
  2. customthe residue was quenched with ice water very carefully
  3. extractionextracted with ethyl acetate
  4. dry with materialThe organic layer was dried over Na2SO4
  5. concentrationconcentrated (the crude product
  6. custompurified by prep-HPLC

出典と根拠

ORDレコード
ord-08d9e5e42db7421891553a097faec604
出典データセット
uspto-grants-2016_07
特許番号
US09388180B2

反応ノート

読み込み中…